|
|
||||||||
J Thorac Cardiovasc Surg 2008;135:1189-1190
© 2008 The American Association for Thoracic Surgery
Letter to the Editor |
Department of Cardiac Surgery, University of Milan, Centro Cardiologico Monzino IRCCS, Milan, Italy
| The first 20% of the full text of this article appears below. |
To the Editor:
I read with great interest the article by Vincentelli and associates.1
In this article the authors present the results of the effects of in situ injection of autologous bone marrow–derived mononuclear cells and mesenchymal stem cells (MSCs) on the outcome of xenogenic decellularized scaffolds in a lamb model. The main focus of this article is on a new method to reseed the cells in valve scaffolds consisting of an in situ injection of bone marrow cells into a porcine decellularized scaffold before implantation. Tissue-engineered heart valves created from MSCs and injected directly in a decellularized xenograft scaffold exhibited satisfactory hemodynamic aspects after 4 months.
Even
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |